Troubled Biotechs: Alexza, Synvista, Alseres, Bionovo

Alexza says its restructuring should keep it operating well into 2010, but three other companies probably have less time.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet